Trial intelligence / Profile preview

Fluoxetine for skin repigmentation in adults with vitiligo

RBR-6xmd7xPhase 2Recruiting

Sponsor
Universidade Federal de Sergipe
Start
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Vitiligo comparing Vitiligo Placebo with Vitiligo Fluoxetine (2 arms). Started Jul 2018; status: recruiting.

02

Drugs

fluoxetine
03

Conditions

Vitiligo

Beyond the preview

Go deeper on RBR-6xmd7x.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-6xmd7x.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call